Multivariate versus classical univariate calibration methods for spectrofluorimetric data: Application to simultaneous determination of olmesartan medoxamil and amlodipine besylate in their combined dosage form

Journal of Fluorescence

Volumn 23, Issue 1, 2013, Pages 79-91

  Darwish, Hany W ^a,b   Backeit, Ahmed H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Amlodipine besylate; Multivariate calibration methods; Olmesartan medoxamil; Pharmaceutical tablets; Spectrofluorimetry

Indexed keywords

AMLODIPINE; MULTIVARIATE CALIBRATION METHODS; OLMESARTAN MEDOXAMIL; PHARMACEUTICAL TABLETS; SPECTROFLUORIMETRY;

BINARY MIXTURES; BLOOD PRESSURE; MULTIVARIABLE SYSTEMS; PRINCIPAL COMPONENT ANALYSIS;

CALIBRATION;

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BUFFER; IMIDAZOLE DERIVATIVE; OLMESARTAN; SOLVENT; TETRAZOLE DERIVATIVE;

ARTICLE; CALIBRATION; CHEMISTRY; COMPARATIVE STUDY; METHODOLOGY; MULTIVARIATE ANALYSIS; PH; REGRESSION ANALYSIS; SPECTROFLUOROMETRY; TIME;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BUFFERS; CALIBRATION; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; LEAST-SQUARES ANALYSIS; MULTIVARIATE ANALYSIS; SOLVENTS; SPECTROMETRY, FLUORESCENCE; TETRAZOLES; TIME FACTORS;

PROTEIDAE; PROTEUS ANGUINUS;

EID: 84873207179     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-012-1119-0     Document Type: Article

References (55)

1. Koga K, Yamagishi S, Takeuchi M, Inagaki Y, Amano S, Okamoto T, Saga T, Makita Z, Yoshizuka M (2002) CS-866, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats. Mol Med Camb MA NY 8(10):591-599
2. Schwocho LR, Masonson HN (2001) Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol 41(5):515-527
3. Celebier M, Altinoz S (2007) Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry. Pharm Int J Pharm Sci 62(6):419-422
4. Gowrishankar D, Sharma T, Si S (2010) Difference spectrophotometric method for the determination of olmesartan medoxomil in tablets. J Pharm Res 3(7)
5. Patel J, Kevin G, Patel A, Raval M, Sheth N (2011) Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies. Pharm Methods 2(1):36
6. Rote AR, Bari PD (2009) Ratio spectra derivative and zero-crossing difference spectrophotometric determination of olmesartan medoxomil and hydrochlorothiazide in combined pharmaceutical dosage form. AAPS PharmSciTech 10(4):1200-1205. doi: 10.1208/s12249-009-9318-y
7. Rote AR, Bari PD (2010) Spectrophotometric estimation of olmesartan medoxomil and hydrochlorothiazide in tablet. Indian J Pharm Sci 72(1):111-113. doi: 10.4103/0250-474X.62245
8. Farouk M, EL-Aziz OA, Hemdanb A, Shehata M (2011) Simple novel spectrophotometric and spectrofluorimetric methods for determination of some anti-hypertensive drugs. J Am Sci 7(1)
9. Hemke A, Bhure M, Chouhan K, Gupta K, Wadodkar S (2010) UV Spectrophotometric determination of hydrochlorothiazide and olmesartan medoxomil in pharmaceutical formulation. E-J Che 7:1156-1161
10. Shah N, Suhagia B, Shah R, Patel N (2007) Development and validation of a simultaneous HPTLC method for the estimation of olmesartan medoxomil and hydrochlorothiazide in tablet dosage form. Indian J Pharm Sci 69(6):834
11. Liu D, Hu P, Matsushima N, Li X, Li L, Jiang J (2007) Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B 856(1-2):190-197
12. Vaidya VV, Roy SMN, Yetal SM, Joshi SS, Parekh SA (2008) LC-MS-MS determination of olmesartan in human plasma. Chromatographia 67(1):147-150
13. Celebier M, Altinöz S (2007) Development of a CZE method for the determination of olmesartan medoxomil in tablets. Chromatographia 66(11):929-933
14. Çelebier M, Altinöz S (2009) Application of capillary electrophoresis to investigate the degradation kinetic of olmesartan medoxomil. Lat Am J Pharm 28(1):108-111
15. Murakami T, Konno H, Fukutsu N, Onodera M, Kawasaki T, Kusu F (2008) Identification of a degradation product in stressed tablets of olmesartan medoxomil by the complementary use of HPLC hyphenated techniques. J Pharm Biomed Anal 47(3):553-559
16. Patel CV, Khandhar AP, Captain AD, Patel KT (2009) Validated absorption factor spectrophotometric and reversed-phase high-performance liquid chromatographic methods for the determination of ramipril and olmesartan medoxomil in pharmaceutical formulations. Eurasian J Anal Chem 2(3):159-171
17. Sweetman SC (2009) Martindale-the complete drug reference, 36th edn. The Pharmaceutical Press, London
18. The British Pharmacopoeia (2010) Her Majesty's Stationery Office:, London
19. Barman RK, Islam MA, Ahmed M, Ibne Wahed MI, Islam R, Khan A, Hossain MB, Rahman BM (2007) Simultaneous high-performance liquid chromatographic determination of atenolol and amlodipine in pharmaceutical-dosage form. Pak J Pharm Sci 20(4):274-279
20. Muthu AK, Gupta TR, Sharma S, Smith AA, Manavalan R, Kannappan N (2008) Simultaneous estimation of amlodipine and atorvastatin in tablets using orthogonal function ratio spectrometry. Int J Chem Sci 6(4):2233-2241
21. Saxena C, Chturvedi S (2009) Simultaneous estimation of amlodipine besylate and benazepril hydrochloride using derivative spectroscopy. Asian J Chem 21(5):4118-4120
22. Abdel-Wadood HM, Mohamed NA, Mahmoud AM (2008) Validated spectrofluorometric methods for determination of amlodipine besylate in tablets. Spectrochim Acta A Mol Biomol Spectrosc 70(3):564-570. doi: 10.1016/j.saa.2007.07.055
23. Shaalan RA, Belal TS (2010) Simultaneous spectrofluorimetric determination of amlodipine besylate and valsartan in their combined tablets. Drug Test Anal 2(10):489-493. doi: 10.1002/dta.160
24. Gazy AA (2004) Determination of amlodipine besylate by adsorptive square-wave anodic stripping voltammetry on glassy carbon electrode in tablets and biological fluids. Talanta 62(3):575-582. doi: 10.1016/j.talanta.2003.08.025
25. Kazemipour M, Ansari M, Mohammadi A, Beitollahi H, Ahmadi R (2009) Use of adsorptive square-wave anodic stripping voltammetry at carbon paste electrode for the determination of amlodipine besylate in pharmaceutical preparations. J Anal Chem 64(1):65-70
26. Dongre VG, Shah SB, Karmuse PP, Phadke M, Jadhav VK (2008) Simultaneous determination of metoprolol succinate and amlodipine besylate in pharmaceutical dosage form by HPLC. J Pharm Biomed Anal 46(3):583-586. doi: 10.1016/j.jpba.2007.11.006
27. Joshi SJ, Karbhari PA, Bhoir SI (2009) RP-LC simultaneous determination of nebivolol hydrochloride and amlodipine besilate in bi-layer tablets. Chromatographia 70(3):557-561
28. Bahrami G, Mirzaeei S (2004) Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies. J Pharm Biomed Anal 36(1):163-168. doi: 10.1016/j.jpba.2004.05.016
29. Baranda AB, Jimenez RM, Alonso RM (2004) Simultaneous determination of five 1,4-dihydropyridines in pharmaceutical formulations by high-performance liquid chromatography-amperometric detection. J Chromatogr A 1031(1-2):275-280
30. Massaroti P, Moraes L, Marchioretto M, Cassiano N, Bernasconi G, Calafatti S, Barros F, Meurer E, Pedrazzoli J (2005) Development and validation of a selective and robust LC-MS/MS method for quantifying amlodipine in human plasma. Anal Bioanal Chem 382(4):1049-1054
31. Zou Q, Zhan Y, Ge Z, Wei P, Ouyang P (2009) Liquid chromatography-mass spectrometry method for the determination of amlodipine in human plasma and its application in a bioequivalence study. Arzneim Forsch 59(8):383-391
32. Kakde R, Bawane N (2009) High-performance thin-layer chromatographic method for simultaneous analysis of metoprolol succinate and amlodipine besylate in pharmaceutical preparations. JPC J Planar Chromatogr Mod TLC 22(2):115-119
33. Fakhari AR, Nojavan S, Haghgoo S, Mohammadi A (2008) Development of a stability-indicating CE assay for the determination of amlodipine enantiomers in commercial tablets. Electrophoresis 29(22):4583-4592. doi: 10.1002/elps. 200800330
34. Martinez V, Lopez JA, Alonso RM, Jimenez RM (1999) Micellar electrokinetic chromatography as a fast screening method for the determination of 1,4-dihydropyridine calcium antagonists. J Chromatogr A 836(1):189-199
35. Mehulkumar P, Ramesh V, VinayKumar V, Srinivas R, Diwan P (2009) Simultaneous spectroscopic estimation of amlodipine besylate and olmesartan medoximil in tablet dosage form. Asian J Res Chem 2:127-132
36. Wankhede SB, Wadkar SB, Raka KC, Chitlange SS (2009) Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form. Indian J Pharm Sci 71(5):563-567. doi: 10.4103/0250-474X.58190
37. Kardile D, Kalyane N, Thakkar T, Patel M, Moradiya R (2010) Simultaneous estimation of amlodipine besylate and olmesartan medoxomil drug formulations by HPLC and UV-spectrophotometric methods. J Pharm Sci Res 2(9):599-614
38. Patil P, Barge V, More H, Piswikar S (2011) Spectrophotometric method for simultaneous determination of olmesartan medoxamil and amlodipine besylate from tablet dosage form. Int J Curr Pharm Res 3(2):74-79
39. Sharma H, Jain N, Jain S (2011) Development of spectrophotometric method for quantitative estimation of amlodipine besylate, olmesartan medoxomil and hydrochlorthiazide in tablet dosage form. Pharm Anal Acta 2(126):2
40. Patil Pournima S, Chivate Niranjan D, Shinde Shubhangi S (2011) Simulteneous determination of Olmesartan medoxomil and Amlodipine besylate from tablet formulation by multiwavelength method. Int J Pharm Tech 3:267-272
41. Patil PS, Kulkarni PD, Burkul MS, More HN, Pishawikar SA (2011) Simultaneous estimation of amlodipine besylate and olmesartan medoxomil by first order derivative spectroscopy from tablet. Int J PharmTech Res 3:668-675
42. Sharma T, Mishra N, Si SC, Shankar DG (2010) Simultaneous estimation of olmesartan medoxomil and amlodipine besylate in solid dosage form by UV spectrophotometry. Pharm Lettre 2:302-307
43. Patil KR, Rane VP, Sangshetti JN, Yeole RD, Shinde DB (2010) Stability indicating LC method for the simultaneous determination of amlodipine and olmesartan in dosage form. J Chromatogr Sci 48(7):601-606
44. Kamble AY, Mahadik MV, Khatal LD, Dhaneshwar SR (2010) Validated HPLC and HPTLC method for simultaneous quantitation of amlodipine besylate and olmesartan medoxomil in bulk drug and formulation. Anal Lett 43(2):251-258
45. Brereton RG (1997) Multilevel multifactor designs for multivariatecalibration. Analyst 122(12):1521-1529
46. Kramer R (1998) Chemometric techniques for quantitative analysis. CRC
47. Lucasius CB, Kateman G (1993) Understanding and using genetic algorithms part 1. Concepts, properties and context. Chemom Intell Lab Syst 19(1):1-33
48. Lucasius CB, Kateman G (1994) Understanding and using genetic algorithms part 2. Representation, configuration and hybridization. Chemom Intell Lab Syst 25(2):99-145
49. Hibbert DB (1993) Genetic algorithms in chemistry. Chemom Intell Lab Syst 19(3):277-293
50. Michalewicz Z (1996) Genetic algorithms + data structures. Springer
51. Leardi R (2000) Application of genetic algorithm-PLS for feature selection in spectral data sets. J Chemom 14(5-6):643-655
52. Leardi R, Seasholtz MB, Pell RJ (2002) Variable selection for multivariate calibration using a genetic algorithm: prediction of additive concentrations in polymer films from Fourier transform-infrared spectral data. Anal Chim Acta 461(2):189-200
53. Demuth H, Beale M, Hagan M (2009) MATLAB user's guide Neural Network toolbox™ version 6. MathWorks Inc, Massahusetts
54. Khanchi AR, Mahani MK, Hajihosseini M, Maragheh MG, Chaloosi M, Bani F (2007) Simultaneous spectrophotometric determination of caffeine and theobromine in Iranian tea by artificial neural networks and its comparison with PLS. Food Chem 103(3):1062-1068
55. Abbaspour A, Baramakeh L (2006) Application of principle component analysis-artificial neural network for simultaneous determination of zirconium and hafnium in real samples. Spectrochim Acta A Mol Biomol Spectrosc 64(2):477-482